Company News

    • February 2017             Semorex CSO, Bernard Green presented a lecture entitled "Platform Technology for Protein Imprinted Polymers: Novel Approach for Treatment of Inflammatory Bowel Diseases" at the 7th Annual MDDMI - Conference and Exhibition for the Medical Device Design, Manufacturing & Innovation, Tel Aviv, Israel

    • January 2017            Semorex senior chemist, Rina Arad Yellin, presented a lecture entitled "New, Reliable Routes to Protein Imprinted Polymers” in IISER, Pune, India.

    • June 2016                Semorex CSO, Bernard Green presented an Invited Lecture entitled, “A novel, step-wise approach to protein-imprinted polymers (a guide for the perplexed protein imprinter)” at the 9th international Conference on Molecular Imprinting, Lund, Sweden.

    •  March 2016            Semorex CSO, Bernard Green presented an Invited Lecture entitled, “Novel Diagnostic for Invasive Fungal Diseases (IFD)” at the Outsourcing in Clinical Trials Israel 2016 meeting, Tel Aviv, Israel.

    • February 2016         Semorex senior biologist, David Dweck presented a lecture entitled “New, Reliable Routes to Protein Imprinted Polymers” at the ICS 81 – Annual meeting of the Israeli Chemical Society, Tel-Aviv, Israel.

    • December 2015       A Seal of Excellence Certificate was awarded to Semorex Technologies Ltd. for project proposal 712584, “Egro4IFD: Rapid Systemic Invasive Fungal Diseases Diagnosis using Ergosterol”, submitted under the Horizon 2020 SME Instrument Phase 2 Call (H2020-SMEINST-2-2015) 17 September 2015, in the area of Clinical research for the validation of biomarkers and/or diagnostic medical devices.

    • December 2015         Semorex Technologies Ltd. was awarded a one-year grant by the Office of Chief Scientist, Ministry of Economy (Tnufa-Program) in cooperation with MASHAV (Israel’s Agency for International Development Cooperation; Ministry of Foreign Affairs) to pursue the project, “ErgoLFA: Novel Diagnostic Tool for ‘Hidden Killer’, Invasive Fungal Infection”. The proposal was submitted by Semorex researchers Bernard Green and Rina Arad-Yellin, Semorex Associate, Idan Bodaker and Semorex Consultant, Michael Giladi, MD (Sourasky Medical Center, Tel Aviv).

    • November 2015        An US Provisional Patent Application No. 62/254,301 entitled “PROTEIN IMPRINTED POLYMERS” was filed to cover the novel approaches developed by Semorex for the preparation and characterization of such polymers and selected applications. The Inventors are: Bernard S. Green, David Dweck Rina Arad-Yellin, Ori Cohavi, and Doron Eren.

    • November 2015       Semorex CSO, Bernard Green presented an Invited Lecture entitled, “Protein Imprinted Polymers. What’s The Problem Here?” at the EFMC-ASMC’15 - European Federation of Medicinal Chemistry International Symposium on Advances in Synthetic and Medicinal Chemistry, Rehovot, Israel.

    • March 2015           Semorex Technologies Ltd. was awarded a one-year grant by the Office of Chief Scientist, Ministry of Economy, as part of the Eureka (Bilateral Cooperation Program Hungary-Israel) program. The project “PIP-4-CD: TNFa– binding Polymers for Oral Delivery Therapy in Crohn’s Disease” is conducted in collaboration with Dr. Tamas Letoha of Pharmacoidea, Szeged, Hungary. The Semorex Technologies team includes Bernard Green, Rina Arad-Yellin, and David Dweck.